Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

被引：1
|
作者：
Statler, Abby [1 ]
Hobbs, Brian P. [2 ]
Radivoyevitch, Tomas [3 ,4 ]
Mukherjee, Sudipto [5 ]
Bell, Kimberly [6 ]
Advani, Anjali S. [5 ]
Gerds, Aaron T. [5 ]
Nazha, Aziz [5 ]
Patel, Bhumika J. [5 ]
Carraway, Hetty E. [5 ]
Sekeres, Mikkael A. [5 ]
机构：
[1] Cleveland Clin, Canc Biostatist, Shaker Hts, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Dept Quantitat Hlth Sci, Cleveland, OH USA
[4] Dept Translat Hematol & Oncol Res, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA
[6] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129096
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
381
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Unveiling inequities in representation: Racial disparities in supportive care breast cancer clinical trial enrollment
    Reyes, Kevin R.
    Lau, Bryan Hill-Fung
    Tang, Felicia
    Gardner, Bianca
    Cui, Kathleen
    Trejo, Evelin
    Manana, Ana I. Velazquez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Eliminating racial disparities in endometrial cancer clinical trial enrollment in the Deep South: a pathway to equity
    Jones, Nathaniel
    Wilhite, Annelise
    Paladugu, Rajesh
    Tinker, Nicholas
    Hude, Christine
    Scalici, Jennifer
    Pierce, Jennifer Young
    Conrads, Thomas
    Darcy, Kathleen
    Maxwell, G. Larry
    Rocconi, Rodney
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S6 - S6
  • [43] How Do Differences in Treatment Impact Racial and Ethnic Disparities in Acute Myeloid Leukemia?
    Patel, Manali I.
    Ma, Yifei
    Mitchell, Beverly
    Rhoads, Kim F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (02) : 344 - 349
  • [44] Racial and ethnic disparities in the incidence and mortality trends of acute myeloid leukemia in the United States
    Kang, Lixin
    Ma, Xiaomei
    Podoltsev, Nikolai A.
    Stempel, Jessica M.
    Wang, Rong
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [45] Racial disparities in patients with TP53 mutated acute myeloid leukemia.
    Badar, Talha
    Litzow, Mark Robert
    Shallis, Rory
    Stahl, Maximilian
    Bewersdorf, Jan Philipp
    Saliba, Antoine N.
    Correia, Guilherme Sacchi De Camargo
    Patel, Anand Ashwin
    Abaza, Yasmin
    Murthy, Guru Subramanian Guru
    Duvall, Adam
    Burkart, Madelyn
    Al-Kali, Aref
    Palmisiano, Neil
    Dinner, Shira
    Goldberg, Aaron David
    Atallah, Ehab L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19007 - E19007
  • [46] Characterization of Extramedullary Acute Myeloid Leukemia - Results of the AML96 Trial
    Stolzel, Friedrich
    Roellig, Christoph
    Kramer, Michael
    Mohr, Brigitte
    Oelschlaegel, Uta
    Radke, Joergen
    Thiede, Christian
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Schaich, Markus
    BLOOD, 2010, 116 (21) : 889 - 890
  • [47] Health state utilities associated with treatment options for acute myeloid leukemia (AML)
    Matza, Louis S.
    Deger, Kristen A.
    Howell, Timothy A.
    Koetter, Kimberly
    Yeager, Andrew M.
    Hogge, Donna
    Fisher, Vicki
    Louie, Arthur C.
    Chung, Karen C.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (06) : 567 - 576
  • [48] HEALTH STATE UTILITIES ASSOCIATED WITH TREATMENT OPTIONS FOR ACUTE MYELOID LEUKEMIA (AML)
    Matza, L. S.
    Deger, K.
    Howell, T.
    Hillgruber, N. K.
    Yeager, A. M.
    Hogge, D.
    Fisher, V
    Louie, A. C.
    Chung, K. C.
    VALUE IN HEALTH, 2017, 20 (09) : A448 - A448
  • [49] CLINICAL IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA (AML)
    Venditti, A.
    Buzzatti, E.
    Guarnera, L.
    Bonanni, F.
    Moretti, F.
    Pascale, M. R.
    Mallegni, F.
    Palmieri, R.
    Paterno, G.
    Del Principe, M. I.
    Maurillo, L.
    Voso, M. T.
    Buccisano, F.
    HAEMATOLOGICA, 2021, 106 (10) : 202 - 205
  • [50] Anticardiolipin antibodies in acute myeloid leukemia (AML): Prevalence and clinical significance.
    Lossos, IS
    Matzner, Y
    BLOOD, 1997, 90 (10) : 3713 - 3713
12345